NPY2R and metabolic syndrome: Some of the NPY receptors mediate neuroendocrine effects and, among these, NPY1R expression in fat cells is associated with the development of MetS by promoting insulin resistance and fat mass accumulation, whereas some variants of NPY2R may influence cardiometabolic traits [11,79,80,81].